{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":2,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"4aed924b31d0","filters":{"venue":"Cytokines Cellular & Molecular Therapy"}},"results":[{"id":"W2073019201","doi":"10.1080/13684730210002319","title":"Increased IFN-? synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Cytokines Cellular & Molecular Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Imatinib; Medicine; Cytokine; Myeloid leukemia; Immunology; Tyrosine-kinase inhibitor; White blood cell; Myeloid; Stem cell; Internal medicine; Cancer; Biology","authors":[{"name":"Jorg M Aswald","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"S. Aswald","is_ca":true},{"name":"Hans A. Messner","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01426710452637617,"gpt":0.2301412151038687,"spread":0.2158741105774925,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001828549,0.0009254205,0.001037931,0.0002125958,0.0002321128,0.00008287744,0.0004921391,0.0004263498,0.001945916],"category_scores_gemma":[0.00009639396,0.0007920283,0.00068183,0.0003384828,0.0001527853,0.000116348,0.00004699776,0.0003565673,0.0004854602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002117528,"about_ca_system_score_gemma":0.0002659683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003329859,"about_ca_topic_score_gemma":0.00000391005,"domain_scores_codex":[0.9960198,0.0002239781,0.0007480126,0.001214771,0.0008538932,0.0009395839],"domain_scores_gemma":[0.9970629,0.000433269,0.0003588952,0.001533258,0.0002041654,0.0004075016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001241787,0.001428557,0.0007149054,0.00005473162,0.000874618,0.0001025368,0.0001902473,0.00003280277,0.8874109,0.0000161976,0.007467912,0.1004648],"study_design_scores_gemma":[0.02121759,0.001925657,0.0007011218,0.0001871607,0.0001743203,0.00000419229,0.00001519388,0.001884029,0.9073583,0.00007911306,0.06578276,0.0006704953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823524,0.01120936,0.001063267,0.0003099365,0.0003295513,0.003151014,0.0005112817,0.0002549348,0.0008182161],"genre_scores_gemma":[0.9889282,0.00388222,0.001252334,0.002148812,0.0004155156,0.0009076276,0.001378524,0.0003430894,0.0007436756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09979425,"threshold_uncertainty_score":0.9994531,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039946232","doi":"10.1080/13684730412331302063","title":"Intracellular cytokine analysis of interferon-? in T cells of patients with chronic myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Cytokines Cellular & Molecular Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Medical Research Council Canada","keywords":"Cytokine; Myeloid leukemia; Immunology; Interferon; Intracellular; Medicine; Myeloid; Leukemia; Cancer research; Biology; Cell biology","authors":[{"name":"Jorg M Aswald","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Hans A. Messner","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009742204197778038,"gpt":0.2181094341677675,"spread":0.2083672299699894,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001768495,0.0005817005,0.001534603,0.001140381,0.00003419807,0.00001345006,0.0003735996,0.0002581975,0.001142372],"category_scores_gemma":[0.00002149113,0.0004795383,0.0005225558,0.002379053,0.0002799206,0.0001076073,0.00007815851,0.0003551228,0.00002589134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001339616,"about_ca_system_score_gemma":0.0002273021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002088652,"about_ca_topic_score_gemma":0.00003879641,"domain_scores_codex":[0.9966339,0.0001478755,0.001059073,0.0007394758,0.0008213265,0.0005983482],"domain_scores_gemma":[0.9975919,0.00006912869,0.0005252698,0.001324938,0.0002995944,0.0001892236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001145214,0.001421724,0.05991298,0.0002034093,0.00367689,0.0003102882,0.0004819257,0.003977788,0.9217448,0.00004473197,0.00002269902,0.007057518],"study_design_scores_gemma":[0.01430036,0.002299877,0.02825838,0.0002389586,0.001470643,0.000004597914,0.00003160069,0.008285594,0.9436202,0.00001046301,0.001040373,0.0004389409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917275,0.005057096,0.001528857,0.00004854482,0.00007861149,0.001094138,0.00006421586,0.00004548554,0.0003555551],"genre_scores_gemma":[0.9975157,0.000948163,0.0006311536,0.00008488658,0.00004178865,0.00004934144,0.0003955031,0.0001111753,0.0002223053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03165459,"threshold_uncertainty_score":0.9997707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}